Depressive symptoms and cognitive deficits in a cancer patient submitted to chemotherapy with 5-fluoracil. a case report Report as inadecuate




Depressive symptoms and cognitive deficits in a cancer patient submitted to chemotherapy with 5-fluoracil. a case report - Download this document for free, or read online. Document in PDF available to download.

Célia Petrossi Gallo Garcia ; Bernardo de Mattos Viana ; Cássio Machado de Campos Bottino ;Dementia & Neuropsychologia 2013, 7 3

Author: Sara Mota Borges Bottino

Source: http://www.redalyc.org/articulo.oa?id=339529044013


Teaser



Dementia & Neuropsychologia ISSN: 1980-5764 demneuropsy@uol.com.br Associação Neurologia Cognitiva e do Comportamento Brasil Borges Bottino, Sara Mota; Gallo Garcia, Célia Petrossi; de Mattos Viana, Bernardo; de Campos Bottino, Cássio Machado Depressive symptoms and cognitive deficits in a cancer patient submitted to chemotherapy with 5Fluoracil.
A case report Dementia & Neuropsychologia, vol.
7, núm.
3, julio-septiembre, 2013, pp.
308-311 Associação Neurologia Cognitiva e do Comportamento São Paulo, Brasil Available in: http:--www.redalyc.org-articulo.oa?id=339529044013 How to cite Complete issue More information about this article Journals homepage in redalyc.org Scientific Information System Network of Scientific Journals from Latin America, the Caribbean, Spain and Portugal Non-profit academic project, developed under the open access initiative Case Report Dement Neuropsychol 2013 September;7(3):308-311 Depressive symptoms and cognitive deficits in a cancer patient submitted to chemotherapy with 5-Fluoracil A case report Sara Mota Borges Bottino1, Célia Petrossi Gallo Garcia2, Bernardo de Mattos Viana2, Cássio Machado de Campos Bottino2 Abstract.
Cognitive deficits in cancer patients can be related to depression, anxiety, and the side effects of treatments such as fatigue.
In this case report, we described an elderly patient with rectal adenocarcinoma, which presented depressive symptoms and memory complaints after treatment with 5-Fluoracil and Leucovorin.
Depressive symptoms improved after two months but cognitive and functional impairment worsened suggesting the diagnosis of mild dementia.
Structural and functional brain changes were seen on neuroimaging exams.
Rivastigmine was introduced up to 12 mg-day, and after a one-year follow up the patient remained stable.
Cognitive deficits can be a consequence of cancer therapies and a protocol to investigate deficits cognitive could be useful to the diferential diagnosis and management of elderl...





Related documents